Bo Kruse - Apr 26, 2022 Form 4 Insider Report for Y-mAbs Therapeutics, Inc. (YMAB)

Role
EVP, CFO, Secretary & Treas.
Signature
/s/ Bo Kruse
Stock symbol
YMAB
Transactions as of
Apr 26, 2022
Transactions value $
$0
Form type
4
Date filed
4/28/2022, 06:16 PM
Previous filing
Feb 23, 2022
Next filing
Jan 19, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction YMAB Employee Stock Option (right to buy) Award $0 +75K $0.00 75K Apr 26, 2022 Common Stock 75K $9.51 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock options granted to the Reporting Person pursuant to the 2018 Equity Incentive Plan of Y-mAbs Therapeutics, Inc.
F2 The stock options shall vest and become exercisable as to 50% of the shares subject to the options on April 26, 2023 and as to the remaining 50% of the shares subject to the options on April 26, 2024, subject to the continuing employment of the Reporting Person on each vesting date.